VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
419
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
84
Interactions with Platform & by Email
PARTICIPANTS
17
Unique # Participated
VALIDATIONS
8
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
111
PAGES
183
EDITION
6
PRICE
USD $4950
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the Viral Inactivation Market?
Amid the COVID-19 crisis, the global market for Viral Inactivation estimated at US$443.1 Million in the year 2020, is projected to reach a revised size of US$951.1 Million by 2027, growing at a CAGR of 11.5% over the analysis period 2020-2027. Kits & Reagents, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$549.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Systems segment is readjusted to a revised 12.1% CAGR for the next 7-year period.
The Viral Inactivation market in the U.S. is estimated at US$130.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$166.8 Million by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 10.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$57.2 Million in the year 2020 will reach a projected size of US$115.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$112.3 Million by the year 2027.We bring years of research experience to this 6th edition of our report. The 183-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Charles River Laboratories International, Inc.; Clean Cells Inc.; Danaher Corporation; Merck KgaA; Parker Hannifin Corporation; Rad Source Technologies, Inc.; Sartorius AG; SGS Group (SGS SA); Texcell, Inc.; V.I.P.S. SA; WuXi AppTec Group
» Application (Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products, Cellular and Gene Therapy) » Product (Kits & Reagents, Systems, Services)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Viral Inactivation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Viral Inactivation Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Viral Inactivation Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Viral Inactivation Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Kits & Reagents (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Kits & Reagents (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Kits & Reagents (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Systems (Product) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Systems (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Systems (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Services (Product) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 |
| Services (Product) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017 |
| Services (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Vaccines and Therapeutics (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025 |
| Vaccines and Therapeutics (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Vaccines and Therapeutics (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Stem Cell Products (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Stem Cell Products (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Stem Cell Products (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Blood and Blood Products (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025 |
| Blood and Blood Products (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017 |
| Blood and Blood Products (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Tissue/ Tissue Products (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 |
| Tissue/ Tissue Products (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Tissue/ Tissue Products (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Cellular and Gene Therapy (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025 |
| Cellular and Gene Therapy (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017 |
| Cellular and Gene Therapy (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Viral Inactivation Market Share (in %) by Company: 2019 & 2025 |
| United States Viral Inactivation Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 |
| Viral Inactivation Market in the United States by Product: A Historic Review in US$ Thousand for 2009-2017 |
| United States Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| United States Viral Inactivation Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 |
| Viral Inactivation Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017 |
| Viral Inactivation Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 |
| Canadian Viral Inactivation Historic Market Review by Product in US$ Thousand: 2009-2017 |
| Viral Inactivation Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Canadian Viral Inactivation Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 |
| Viral Inactivation Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 |
| Canadian Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| JAPAN |
| Japanese Market for Viral Inactivation: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 |
| Viral Inactivation Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 |
| Japanese Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Viral Inactivation in US$ Thousand by Application: 2018 to 2025 |
| Japanese Viral Inactivation Market in US$ Thousand by Application: 2009-2017 |
| Viral Inactivation Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Viral Inactivation Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 |
| Viral Inactivation Historic Market Analysis in China in US$ Thousand by Product: 2009-2017 |
| Chinese Viral Inactivation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Viral Inactivation in US$ Thousand by Application: 2018 to 2025 |
| Viral Inactivation Market Review in China in US$ Thousand by Application: 2009-2017 |
| Chinese Viral Inactivation Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| EUROPE |
| Market Facts & Figures |
| European Viral Inactivation Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Viral Inactivation Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Viral Inactivation Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Viral Inactivation Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 |
| Viral Inactivation Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 |
| European Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| European Viral Inactivation Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 |
| Viral Inactivation Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 |
| European Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| FRANCE |
| Viral Inactivation Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Viral Inactivation Historic Market Scenario in US$ Thousand by Product: 2009-2017 |
| French Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Viral Inactivation Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025 |
| French Viral Inactivation Historic Market Review in US$ Thousand by Application: 2009-2017 |
| French Viral Inactivation Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| GERMANY |
| Viral Inactivation Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 |
| German Viral Inactivation Historic Market Analysis in US$ Thousand by Product: 2009-2017 |
| German Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Viral Inactivation Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 |
| German Viral Inactivation Market in Retrospect in US$ Thousand by Application: 2009-2017 |
| Viral Inactivation Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Viral Inactivation Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 |
| Viral Inactivation Historic Market Analysis in Italy in US$ Thousand by Product: 2009-2017 |
| Italian Viral Inactivation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Viral Inactivation in US$ Thousand by Application: 2018 to 2025 |
| Viral Inactivation Market Review in Italy in US$ Thousand by Application: 2009-2017 |
| Italian Viral Inactivation Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| UNITED KINGDOM |
| United Kingdom Market for Viral Inactivation: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 |
| Viral Inactivation Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 |
| United Kingdom Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Viral Inactivation in US$ Thousand by Application: 2018 to 2025 |
| United Kingdom Viral Inactivation Market in US$ Thousand by Application: 2009-2017 |
| Viral Inactivation Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 |
| Viral Inactivation Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 |
| Rest of Europe Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Rest of Europe Viral Inactivation Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 |
| Viral Inactivation Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 |
| Rest of Europe Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Viral Inactivation Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Viral Inactivation Historic Market Scenario in US$ Thousand by Product: 2009-2017 |
| Asia-Pacific Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Viral Inactivation Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025 |
| Asia-Pacific Viral Inactivation Historic Market Review in US$ Thousand by Application: 2009-2017 |
| Asia-Pacific Viral Inactivation Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| REST OF WORLD |
| Rest of World Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 |
| Rest of World Viral Inactivation Historic Market Review by Product in US$ Thousand: 2009-2017 |
| Viral Inactivation Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Rest of World Viral Inactivation Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 |
| Viral Inactivation Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 |
| Rest of World Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 42 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com